Related references
Note: Only part of the references are listed.Cryo-EM structures of NPC1L1 reveal mechanisms of cholesterol transport and ezetimibe inhibition
Ching-Shin Huang et al.
SCIENCE ADVANCES (2020)
Recent Updates on Obesity Treatments: Available Drugs and Future Directions
Nathalia R. V. Dragano et al.
NEUROSCIENCE (2020)
Diet and Cardiovascular Disease Risk Among Individuals with Familial Hypercholesterolemia: Systematic Review and Meta-Analysis
Fotios Barkas et al.
NUTRIENTS (2020)
Expedient Synthesis of Alphitolic Acid and Its Naturally Occurring 2-O-Ester Derivatives
Somin Park et al.
JOURNAL OF NATURAL PRODUCTS (2019)
Intracellular Delivery of Native Proteins Facilitated by Cell-Penetrating Poly(disulfide)s
Linghui Qian et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
Design, synthesis, biological evaluation and molecular modelling studies of novel diaryl substituted pyrazolyl thiazolidinediones as potent pancreatic lipase inhibitors
S. N. C. Sridhar et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Potential pancreatic lipase inhibitory activity of phenolic constituents from the root bark of Morus alba L.
Manh Tuan Ha et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Alcoholic beverages, obesity, physical activity and other nutritional factors, and cancer risk: A review of the evidence
Paule Latino-Martel et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Orlistat limits cholesterol intestinal absorption by Niemann-pick C1-like 1 (NPC1L1) inhibition
Saeed Alqahtani et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Elucidating the Biosynthetic Pathway for Vibralactone: A Pancreatic Lipase Inhibitor with a Fused Bicyclic beta-Lactone
Pei-Ji Zhao et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
CETILISTAT FOR THE TREATMENT OF OBESITY
J. Gras
DRUGS OF TODAY (2013)
A new pancreatic lipase inhibitor from Broussonetia kanzinoki
Jong Hoon Ahn et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Niemann-Pick C1-Like 1 (NPC1L1) Protein in Intestinal and Hepatic Cholesterol Transport
Lin Jia et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 73 (2011)
Apoptosis and insulin resistance in liver and peripheral tissues of morbidly obese patients is associated with different stages of non-alcoholic fatty liver disease
D. M. S. Ferreira et al.
DIABETOLOGIA (2011)
The combination of high-fat diet-induced obesity and chronic ulcerative colitis reciprocally exacerbates adipose tissue and colon inflammation
Lilian G. Teixeira et al.
LIPIDS IN HEALTH AND DISEASE (2011)
Tetrahydrolipstatin Analogues as Modulators of Endocannabinoid 2-Arachidonoylglycerol Metabolism
Giorgio Ortar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Orlistat: A review of its use in the management of obesity
Sheridan Henness et al.
DRUGS (2006)
The target of ezetimibe is Niemann-Pick Cl-Like 1 (NPC1L1)
M Garcia-Calvo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Ezetimibe - A review of its metabolism, pharmacokinetics and drug interactions
T Kosoglou et al.
CLINICAL PHARMACOKINETICS (2005)
Carnosic acid, a new class of lipid absorption inhibitor from sage
K Ninomiya et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Niemann-Pick C1 like 1 protein is critical for intestinal cholesterol absorption
SW Altmann et al.
SCIENCE (2004)
Effects of orlistat on obesity-related diseases -: a six-month randomized trial
B Guy-Grand et al.
DIABETES OBESITY & METABOLISM (2004)
Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia - A prospective, randomized, double-blind trial
CM Ballantyne et al.
CIRCULATION (2003)
Effect of orlistat added to diet (30% of calories from fat) on plasma lipids, glucose, and insulin in obese patients with hypercholesterolemia
CP Lucas et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia
RH Knopp et al.
EUROPEAN HEART JOURNAL (2003)
Ezetimibe: A selective cholesterol absorption inhibitor
EA Nutescu et al.
PHARMACOTHERAPY (2003)
Orlistat inhibits dietary cholesterol absorption
B Mittendorfer et al.
OBESITY RESEARCH (2001)
Share Paper
